Eli Lilly and Company

Other

Norman D Brooks

David Edward Tupper

Charles A Bunnell

Thomas H Ferguson

Douglas J Allen

Sharon L Shinkle

Barry A Hendriksen

Manuel V Sanchez-Felix

Stuart J Garvin

Kurt D Dekemper

Linda C Murray

Snehlata S Mascarenhas

Peter W Vanevenhoven

Gregory F Needham

Rebecca A Kenyon

The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.

2-methyl-thieno-benzodiazepine formulation

The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation or olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.

Described is a preferred injectable, extended release formulation which includes a growth hormone or a growth hormone releasing factor in a carrier including a biocompatible hydrophobic vehicle and an amount of polyglycerol ester effective to extend release of the growth hormone or growth hormone releasing factor in an animal. Other preferred embodiments provide methods for making a composition for treating an animal with a growth hormone or growth hormone releasing factor, and methods for administering these substances to an animal.

Injectable extended release formulations and methods

This invention provides a novel formulation of an animal feed premix in substantially granular and non-dusty form comprising finely powdered nicarbazin and a water-soluble adjuvant having a melting point in the range from about 50.degree. to about 85.degree..

Nicarbazin feed premix

Growing community of inventors

Greenfield, IN, United States of America

Norman D Brooks